221 related articles for article (PubMed ID: 21316780)
21. Design of affinity peptides from natural protein ligands: A study of the cardiac troponin complex.
Chandra D; Sankalia N; Arcibal I; Banta S; Cropek D; Karande P
Biopolymers; 2014 Jan; 102(1):97-106. PubMed ID: 24436041
[TBL] [Abstract][Full Text] [Related]
22. REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors.
Andrews MJ; Kontopidis G; McInnes C; Plater A; Innes L; Cowan A; Jewsbury P; Fischer PM
Chembiochem; 2006 Dec; 7(12):1909-15. PubMed ID: 17051658
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.
Colette J; Avé E; Grenier-Boley B; Coquel AS; Lesellier K; Puget K
J Pept Sci; 2007 Sep; 13(9):568-74. PubMed ID: 17694568
[TBL] [Abstract][Full Text] [Related]
24. Computational analysis of ligand relationships within target families.
Bajorath J
Curr Opin Chem Biol; 2008 Jun; 12(3):352-8. PubMed ID: 18312862
[TBL] [Abstract][Full Text] [Related]
25. Ligand-regulated peptides: a general approach for modulating protein-peptide interactions with small molecules.
Binkowski BF; Miller RA; Belshaw PJ
Chem Biol; 2005 Jul; 12(7):847-55. PubMed ID: 16039531
[TBL] [Abstract][Full Text] [Related]
26. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
[TBL] [Abstract][Full Text] [Related]
27. Advances and applications of binding affinity prediction methods in drug discovery.
Parenti MD; Rastelli G
Biotechnol Adv; 2012; 30(1):244-50. PubMed ID: 21856406
[TBL] [Abstract][Full Text] [Related]
28. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score.
Yoshimori A; Takasawa R; Tanuma S
BMC Pharmacol; 2004 May; 4():7. PubMed ID: 15154972
[TBL] [Abstract][Full Text] [Related]
29. High-resolution structural analysis of mammalian profilin 2a complex formation with two physiological ligands: the formin homology 1 domain of mDia1 and the proline-rich domain of VASP.
Kursula P; Kursula I; Massimi M; Song YH; Downer J; Stanley WA; Witke W; Wilmanns M
J Mol Biol; 2008 Jan; 375(1):270-90. PubMed ID: 18001770
[TBL] [Abstract][Full Text] [Related]
30. Structure-based prediction of protein-peptide specificity in Rosetta.
King CA; Bradley P
Proteins; 2010 Dec; 78(16):3437-49. PubMed ID: 20954182
[TBL] [Abstract][Full Text] [Related]
31. Domain Interaction Footprint: a multi-classification approach to predict domain-peptide interactions.
Schillinger C; Boisguerin P; Krause G
Bioinformatics; 2009 Jul; 25(13):1632-9. PubMed ID: 19376827
[TBL] [Abstract][Full Text] [Related]
32. Interactions between peptides containing nucleobase amino acids and T7 phages displaying S. cerevisiae proteins.
Watanabe S; Tomizaki KY; Takahashi T; Usui K; Kajikawa K; Mihara H
Biopolymers; 2007; 88(2):131-40. PubMed ID: 17206624
[TBL] [Abstract][Full Text] [Related]
33. Specific modulation of protein kinase activity via small peptides.
Costa-Junior HM; Suetsugu MJ; Krieger JE; Schechtman D
Regul Pept; 2009 Feb; 153(1-3):11-8. PubMed ID: 19135095
[TBL] [Abstract][Full Text] [Related]
34. Principles and pitfalls in designing site-directed peptide ligands.
Edmundson AB; Harris DL; Fan ZC; Guddat LW; Schley BT; Hanson BL; Tribbick G; Geysen HM
Proteins; 1993 Jul; 16(3):246-67. PubMed ID: 8346191
[TBL] [Abstract][Full Text] [Related]
35. Combinatorial and computational approaches in structure-based drug design.
Kubinyi H
Curr Opin Drug Discov Devel; 1998 Jul; 1(1):16-27. PubMed ID: 19649785
[TBL] [Abstract][Full Text] [Related]
36. Blind predictions of protein interfaces by docking calculations in CAPRI.
Lensink MF; Wodak SJ
Proteins; 2010 Nov; 78(15):3085-95. PubMed ID: 20839234
[TBL] [Abstract][Full Text] [Related]
37. Rational design of peptide ligands against a glycolipid by NMR studies.
Tong W; Sprules T; Gehring K; Saragovi HU
Methods Mol Biol; 2012; 928():39-52. PubMed ID: 22956132
[TBL] [Abstract][Full Text] [Related]
38. In silico methods for design of biological therapeutics.
Roy A; Nair S; Sen N; Soni N; Madhusudhan MS
Methods; 2017 Dec; 131():33-65. PubMed ID: 28958951
[TBL] [Abstract][Full Text] [Related]
39. Computational approaches to developing short cyclic peptide modulators of protein-protein interactions.
Duffy FJ; Devocelle M; Shields DC
Methods Mol Biol; 2015; 1268():241-71. PubMed ID: 25555728
[TBL] [Abstract][Full Text] [Related]
40. Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.
Diller DJ; Swanson J; Bayden AS; Jarosinski M; Audie J
Future Med Chem; 2015; 7(16):2173-93. PubMed ID: 26510691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
